Record participation highlights innovative, patient-centered initiatives advancing cancer care across the FCS statewide network
FORT MYERS, Fla., May 13, 2026 /PRNewswire/ -- Initiatives developed at Florida Cancer Specialists & Research Institute, LLC (FCS) that are positively impacting the quality of cancer care will be presented this week at the Oncology Nursing Society Annual Congress in San Antonio. Twelve abstracts authored by FCS nurses, clinicians and team members who serve in a variety of roles across the statewide practice were among the highest-scoring abstracts selected for presentations at the largest worldwide gathering dedicated to oncology nursing.
"This year marks an exciting milestone, with more nurses than ever from FCS presenting at the 2026 ONS Conference." said Deja Ross-Jenkins, MSN, RN, OCN, FCS director of clinical operations. "We are incredibly proud to see their work shared through posters and abstracts, reflecting the dedication, innovation, and growing impact of oncology nursing within our community practices.
The following FCS clinicians and team members are authors of abstracts that will be featured in presentations at the Oncology Nursing Society Annual Congress:
"We are honored to highlight the groundbreaking work of our dedicated and highly skilled cancer care teams at this prestigious congress," said FCS assistant managing physician David Wenk, MD. "This includes nearly 1,000 oncology nurses across our practice who serve as healers, educators, advocates, researchers and drivers of change. Each day, they are committed to enhancing the quality of life and outcomes for patients with cancer and their families, helping to shape and advance the future of oncology nursing."
All accepted abstracts will be published, as submitted, in the Oncology Nursing Forum following the event.
The Oncology Nursing Society (ONS) is a professional association that represents 100,000 nurses and is the professional home to more than 35,000 members. ONS is committed to advancing excellence in oncology nursing and quality cancer care.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.
FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. Through its robust clinical research program with Sarah Cannon Research Institute (SCRI) and a suite of independent site management programs, with advanced clinical trial matching technology, FCS offers patients innovative therapies close to home. Each year, FCS conducts more than 180 active clinical trials that directly elevate patient care and accelerate progress in oncology. Many of the cancer drugs approved by the FDA in the U.S over the past decade were accessible to patients at FCS through clinical trial participation before receiving approval.
Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
SOURCE Florida Cancer Specialists & Research Institute